The Effects of CD40 Ligand Deficiency on Vascular Dysfunction, Immunoglobulin Production and Lymph Capillary Density in a Murine Model for High-Salt Diet
The Effects of CD40 Ligand Deficiency on Vascular Dysfunction, Immunoglobulin Production and Lymph Capillary Density in a Murine Model for High-Salt Diet
批准号:
290587856
负责人:
Dr. Steffen Daub
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
A high-salt diet is the norm in Western society. It has been shown to be associated with vascular dysfunction, hypertension and increased cardiovascular mortality and morbidity. While this is a widely known and well-proven fact, the mechanism behind the association between high-salt diet and endothelial dysfunction, insulin resisistance, vascular stiffness, metabolic syndrome, attenuated blood pressure dipping and increased inflammation remains incompletely understood. Traditionally, the milieu intérieur, as proposed by Claude Bernard over a century ago, has coined our unterstanding of sodium homeostasis within the body. This model envolves an equilibrium between extracellular electrolyte and water content. Recently, Jens Titze and colleagues were able to revolutionize our understanding of sodium homeostasis, showing that extracellular Sodium is being stored without subsequent water retention, a phenomenon observed in animals fed a high-salt diet. An increase in extracellular Sodium has been shown to lead to the activation of a transcription factor named TonEBP, which is able to translate an excess of interstitial sodium into a (patho-)physiological response. It is of yet unclear, however, which genes and proteins play a part in this translation. With the CD40 Ligand being crucial to the interaction between T cells and B cells, the formation of atherosclerotic plaques and their invasion by cells of the immune system, in silico the gene-sequence belonging to CD40 Ligand is a target for the aforementioned transcription factor TonEBP. Therefore it is highly likely that the (patho-)physiological effects in animals fed a high-salt diet are due to the interaction between TonEBP and the promotor region of CD40 Ligand.In this study, I would like to assess this Interaction in mice lacking CD40 Ligand in three ways: 1. CD40L-/- mice will show impaired immunoglobulin production when subjected to TNP-KHL immunization while fed a high-salt diet. 2. CD40L-/- mice will display reduced lymph capillary density in skin, resulting in impaired Na+ clearance when fed a high-salt diet. 3. CD40L-/- mice fed a high-salt diet will accumulate as much or more osmotically inactive Na+ in the interstitium than their wild-type littermates, thus resulting in an increase in TonEBP activity. While this will cause endothelial dysfunction in wild type animals as mentioned above, CD40L-deficiency will protect the animals from the harmful effects of the transcription factor, thus rendering endothelial function unimpaired.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1172/jci88532
发表时间:
2017-05-01
期刊:
JOURNAL OF CLINICAL INVESTIGATION
影响因子:
15.9
作者:
[Kitada, Kento, Daub, Steffen, Titze, Jens]
通讯作者:
Titze, Jens
Renal physiology: Burning calories to excrete salt
肾脏生理学:燃烧卡路里排泄盐分
DOI:
10.1038/nrneph.2017.62
发表时间:
2017
期刊:
Nature Reviews Nephrology
影响因子:
41.5
作者:
[Rabelink TJ]
通讯作者:
Rabelink TJ
国内基金
海外基金
登录
查看更多内容
EB病毒蛋白BZLF1上调CD40/CD40L-
KU80/RAG信号通路促进BCR二次重排在机
体丧失自身免疫耐受的机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:侯显良
-
依托单位:
CD40激动剂介导巨噬细胞M1极化激活放疗旁观者效应的研究
-
批准号:JCZRYB202500454
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于CD40/TAMS探究益气活血解毒方纳米囊泡诱导卵巢癌富脂微环境冷热转化免疫增效机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:卢雯平
-
依托单位:
基于前列腺癌类器官模型的B7H3靶向ADC药物与CD40协同免疫治疗研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王晓婷
-
依托单位:
CD40/CD40L通路激活CD8+毒性T淋巴细胞调控TED眼眶组织重塑的机制研究
-
批准号:82371105
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:谭佳
-
依托单位:
锰增敏的CD40免疫检查点调控对植入物感染免疫治疗的效应和机制研究
-
批准号:82302717
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:杨闯
-
依托单位:
大弹涂鱼CD40作为MOSPD2共受体调控LEAP2趋化单核巨噬细胞的分子机制
-
批准号:LZ23C190001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:陈炯
-
依托单位:
荷载糖皮质激素和CD40核酸适配体的水凝胶微针用于治疗甲状腺相关性眼病的疗效和机制研究
-
批准号:2023JJ30851
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:熊炜
-
依托单位:
CREBBP/P300调控CD40介导Tfh-B细胞纠缠在肾移植ABMR中的机制研究
-
批准号:LQ23H050004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:郭陆英
-
依托单位:
工程化外泌体表达CD40调控B细胞活性在系统性红斑狼疮治疗中的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:梁欣
-
依托单位: